Mysim Therapeutics Private Limited

Mysim Therapeutics Private Limited - healthcare in Delhi, India. FY 2026 financials & compliance.
CIN U24299DL2020PTC373484 Incorporated 20 November 2020 ROC Delhi HQ Delhi, India
Active Private Limited Company healthcare
Revenue · FY 2025
₹8.37 Cr
▲ 15% YoY
Net profit · FY 2025
₹68.33 Lakh
Net margin 8.2%
EBITDA · FY 2025
₹94.12 Lakh
EBITDA margin 11.2%
Authorised capital
₹14 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Employees · EPFO
50
Provident fund records
Directors on board
2
As per MCA filings

About Mysim Therapeutics Private Limited

Data last updated:

Mysim Therapeutics Private Limited is a private limited company based in Delhi, India. It operates in the preventive healthcare segment of the healthcare sector. It was incorporated on 20 November 2020 and has been in existence for over 6 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24299DL2020PTC373484. Its GSTIN is 07AAOCM0920A1ZX (Delhi).

The company has an authorised share capital of ₹14 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Irshad Ahmad Gojri and Mumtaz Ahmad Siddique.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 220/3 Flat No. 301 Nai Basti Road Abdul Fazal Enclave Jamia Nagar, Delhi, India – 110025.

As per the financials filed for FY 2025, the company reported a revenue of ₹8.37 Cr, a growth of 15% compared to the previous year. For the same year it recorded a net profit of ₹68.33 Lakh (net margin 8.2%) and EBITDA of ₹94.12 Lakh (EBITDA margin 11.2%). Revenue has grown at a compounded annual rate (CAGR) of 45% over three years.

The company has about 50 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Mysim Therapeutics.

For more details, the company can be reached via its website mysimtherapeutics.com.

Company details

CIN U24299DL2020PTC373484
Registration Number 373484
Incorporation Date 20 November 2020
ROC Delhi
Listing Status Unlisted
Company Status Active

Contact details

Mysim Therapeutics Private Limited's registered office is in Delhi, Delhi. Its website is mysimtherapeutics.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    220/3 Flat No. 301 Nai Basti Road Abdul Fazal Enclave Jamia Nagar, Delhi, India – 110025
  • Industry
    Healthcare, Preventive Health Services

To see the full contact details of Mysim Therapeutics Private Limited, buy the company report.

Comprehensive company report
Mysim Therapeutics Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Mysim Therapeutics operates one associated brand: Mysim Therapeutics. Each brand links to its own profile.

BrandDescriptionWebsite
Provision of valued medicines in healthcare sectors like Nephrology and Cardiology.mysimtherapeutics.com

Business activity

The main business activity of Mysim Therapeutics is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GWholesale and retail trade; repair of motor vehicles and motorcycles46Wholesale trade, except of motor vehicles and motorcycles

To see the full business activity and turnover split of Mysim Therapeutics Private Limited, buy the company report.

Financials of Mysim Therapeutics Private Limited

FY 2025 filings available

Mysim Therapeutics Private Limited reported revenue of ₹8.37 Cr (up 15% YoY) for FY 2025.

Revenue · FY 2025
₹8.37 Cr ▲ 15%
Net profit · FY 2025
₹68.33 Lakh margin 8.2%
EBITDA · FY 2025
₹94.12 Lakh margin 11.2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 15%
3 years · compounded
▲ 45%
EBITDA CAGR growth
3 years · compounded
▲ 77%

Revenue has grown at a compounded annual rate (CAGR) of 45% over three years, including 15% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹94.12 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹68.33 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin11.2%
Net Profit Margin8.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Mysim Therapeutics Private Limited, buy the company report.

Board of directors of Mysim Therapeutics Private Limited

Mysim Therapeutics has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Irshad Ahmad GojriDirector22 Mar 20242 Years 7 MonthsCurrent
Mumtaz Ahmad SiddiqueDirector20 Nov 20205 Years 11 MonthsCurrent

Auditor

Mysim Therapeutics Private Limited is audited by S MADNANI & ASSOCIATES for the financial year 2022.

Auditor firmFinancial yearFirm registration number
S MADNANI & ASSOCIATESFY 2022014292N

Shareholding

The shareholding of Mysim Therapeutics Private Limited is on record for FY 2021, split between promoters, domestic institutions, public shareholders and others.

Shareholder categoryFY 2021
Promoters
Domestic institutional investors (DII)
Public
Others

To see the full shareholding pattern of Mysim Therapeutics Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Mysim Therapeutics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Mysim Therapeutics Private Limited has a workforce of 50 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
50
Active EPFO establishments
1
Employee growth
28.2%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-2750
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23

To see the full employee and EPFO history of Mysim Therapeutics Private Limited, buy the company report.

GST

Mysim Therapeutics has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
07AAOCM0920A1ZXDelhiActive16 Jan 2021

To see the full GST registrations and return filing status of Mysim Therapeutics Private Limited, buy the company report.

Recent activity

Mysim Therapeutics Private Limited has 4 board changes on record since 2020: 2 appointments and 2 cessations. The latest: Irshad Ahmad Gojri ceased to be Additional Director on 29 Sep 2024.

AGM
Mysim Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Mysim Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I.
Ceased
Irshad Ahmad Gojri ceased to be Additional Director.
Ceased
Suresh Kumar Sahoo ceased to be Director.
Appointed
Irshad Ahmad Gojri was appointed as Director.
Appointed
Mumtaz Ahmad Siddique was appointed as Director.
Incorporation
20 Nov 2020
Mysim Therapeutics Private Limited was registered on 20 Nov 2020 with Roc Delhi I & aged 5 years 11 months as per MCA records.

Frequently asked questions

Mysim Therapeutics is an active private limited company based in Delhi, India. The company works in preventive health services, within the healthcare industry. It was incorporated on 20 November 2020 (6+ years old) and is registered under CIN U24299DL2020PTC373484.

Mysim Therapeutics has 2 current directors:

The latest financial statements of Mysim Therapeutics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.

The GSTIN of Mysim Therapeutics is 07AAOCM0920A1ZX, registered in Delhi.

The CIN (Corporate Identification Number) of Mysim Therapeutics is U24299DL2020PTC373484. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Mysim Therapeutics was incorporated on 20 November 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.

Irshad Ahmad Gojri ceased to be Additional Director on 29 Sep 2024. Suresh Kumar Sahoo ceased to be Director on 31 Mar 2024. Irshad Ahmad Gojri was appointed as Director on 22 Mar 2024. Mysim Therapeutics has 4 board changes on record in total.

Mysim Therapeutics can be reached through the website mysimtherapeutics.com. Its registered office is in Delhi, India.

The registered office of Mysim Therapeutics is at 2203 Flat No. 301 Nai Basti Road Abdul Fazal Enclave Jamia Nagar, Delhi, India – 110025.

Mysim Therapeutics operates in the healthcare industry, in the preventive health services segment.